Cohort in Qianwan New District, Ningbo
Launched by RENJI HOSPITAL · Apr 25, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how to prevent and manage chronic diseases like heart problems and strokes in the Qianwan New District of Ningbo. The goal is to develop a system that can help identify people at risk for these conditions early on. By doing this, the researchers hope to promote early detection and treatment, which can lead to better health outcomes and lower medical costs, ultimately helping people live longer, healthier lives.
To participate in this study, you need to be a permanent resident of the area and at least 18 years old. You should be able to communicate normally and not have any serious physical disabilities. Participants will voluntarily agree to join and will be asked to sign consent forms. Those who are temporary residents, have severe health issues, or do not wish to undergo follow-up checks will not be eligible. If you decide to participate, you can expect to contribute to important research that could help improve health care for everyone in your community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1) Local permanent residents aged 18 and above (including residents with household registration, or residents without household registration but with a permanent job);
- • 2) No serious physical disability, can communicate normally;
- • 3) Participate voluntarily and sign informed consent.
- Exclusion Criteria:
- • 1) Temporary resident and floating population;
- • 2) There are serious health conditions unable to participate in the survey;
- • 3) Those who are unwilling to accept the follow-up inspection of the project.
About Renji Hospital
Renji Hospital, a prestigious medical institution affiliated with Shanghai Jiao Tong University School of Medicine, is dedicated to advancing healthcare through innovative clinical research. With a strong emphasis on patient-centered care, Renji Hospital conducts a wide range of clinical trials across various therapeutic areas, harnessing cutting-edge technology and evidence-based practices. The hospital's multidisciplinary team of experienced researchers and medical professionals collaborates closely to ensure rigorous study design and execution, aiming to contribute significantly to medical knowledge and improve treatment outcomes for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, , China
Patients applied
Trial Officials
Jun Pu, MD, PhD
Principal Investigator
Ningbo Hangzhou Bay Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported